News

12
May

Dr. Ginhoux joins Genoskin Scientific Advisory Board

PRESS RELEASE - Toulouse, France - May 2022 Dr. Florent Ginhoux joins Genoskin’s Scientific Advisory Board Genoskin is thrilled to welcome Dr. Florent Ginhoux, PhD, to its Scientific Advisory Board (SAB). After last year's nomination of world-renowned immunology expert, Dr. Nicolas Gaudenzio, as Genoskin’s CSO, Dr. Ginhoux will now bring his world-class expertise as Highly Cited Researcher in tissue-resident immune
Read more
27
Apr

Naked Immunology – Webinar 2 – Myeloid Cell Profiling – Florent Ginhoux

Top-level science through the eyes of an expert.The second Webinar. The second webinar in the Naked Immunology series took place on May 10, 2022 at 8 a.m. (PST), 11 a.m. (EST), 5 p.m. (CET). The webinar is open to English-speaking participants with a solid scientific background. Featured speaker is Highly Cited Researcher and immunology expert, Dr. Florent Ginhoux. watch the
Read more
11
Feb

What I Learned In A French Lab That Led To My Role As A CEO

Article by Pascal Descargues, first published in Life Science Leader on February 1, 2022. The original article is available here. What I Learned In A French Lab That Led To My Role As CEO The Path to the Aha Moment In 2006, I had just finished my Ph.D. in human pathophysiology, and I was working in a lab in Toulouse,
Read more
4
Jan

Genoskin CSO obtains high-profile career award

GENOSKIN CSO OBTAINS HIGH-PROFILE CAREER AWARD To start the new year in good cheer, Genoskin is proud to announce that Dr. Nicolas Gaudenzio, our Chief Scientific Officer and Principal Investigator at Infinity, has recently obtained the Arloing-Courmont-Pasteur Institute career achievement award in human biology from the Academy of Science in Lyon, France. An award to highlight innovative scientific research The
Read more
3
Jan

Better Technology for Reliable Drug Development

CREATING BETTER TECHNOLOGY FOR RELIABLE DRUG DEVELOPMENT STUDIES Changing drug development as we know it Genoskin aims to change drug development technology as we know it. We combine artificial intelligence and cutting-edge technology with live ex vivo human tissue to efficiently help pharmaceutical and biotech companies develop new drugs and vaccines in a better, faster and more cost-efficient way. And
Read more
6
Dec

Genoskin launches spatial skin biology platform MANTIS®

PRESS RELEASE - Toulouse, France & Salem, MA, USA - December 6, 2021 GENOSKIN LAUNCHES SPATIAL SKIN BIOLOGY PLATFORM MANTIS® Genoskin launches MANTIS®, a spatial biology imaging platform dedicated to skin immunology. The MANTIS® (Multiplex ANnotated Tissue Imaging System) platform was developed at Infinity (Inserm U1291, France) by a team of experts under the guidance of Dr. Nicolas Gaudenzio, who
Read more